Home/Filings/4/0001127602-22-003424
4//SEC Filing

Avruch Steven 4

Accession 0001127602-22-003424

CIK 0001681087other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 5:19 PM ET

Size

7.3 KB

Accession

0001127602-22-003424

Insider Transaction Report

Form 4
Period: 2022-02-02
Avruch Steven
VP & General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-02+90,00090,000 total
    Exercise: $1.84Exp: 2032-02-01Common Stock (90,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2022-02-02+105,000105,000 total
    Exercise: $1.84Exp: 2032-02-01Common Stock (105,000 underlying)
Footnotes (1)
  • [F1]25% of the shares shall vest and become exercisable on February 2, 2023, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period.

Issuer

AVROBIO, Inc.

CIK 0001681087

Entity typeother

Related Parties

1
  • filerCIK 0001762236

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:19 PM ET
Size
7.3 KB